Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1984-1-7
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0362-5664
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S9-26
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6139168-Antipsychotic Agents,
pubmed-meshheading:6139168-Basal Ganglia Diseases,
pubmed-meshheading:6139168-Diagnosis, Differential,
pubmed-meshheading:6139168-Dyskinesia, Drug-Induced,
pubmed-meshheading:6139168-Humans,
pubmed-meshheading:6139168-Parkinson Disease, Secondary,
pubmed-meshheading:6139168-Risk
|
pubmed:year |
1983
|
pubmed:articleTitle |
Neuroleptic-induced extrapyramidal reactions: classification, description, and diagnosis.
|
pubmed:publicationType |
Journal Article,
Review
|